TGFβRI-IN-2 is a potent, selective, and orally active inhibitor of activin receptor-like kinase 5 (ALK5), with pIC50 and pEC50 values of 7.6 and 6.63, respectively; it has been used in research to study ALK5-mediated signaling pathways and TGF-β-related biological processes.